Laboratorios Del Dr Esteve competitive analysis

Explore Laboratorios Del Dr Esteve's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
Aug 4, 2021Oral Pharmaceutical Compositions Of Dabigatran Etexilate3
Oct 1, 20141-Aryl-3-Aminoalkoxy Pyrazoles As Sigma Ligands Enhancing Analgesic Effect Of Opioids And Attenuating The Dependency Thereof1

Latest PTAB cases involving Laboratorios Del Dr Esteve

Discover the latest PTAB cases involving Laboratorios Del Dr Esteve, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Laboratorios Del Dr Esteve with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LABORATORIOS DEL DR ESTEVE - 4 - -
AERA25 - - -
GALLAFENT, ALISON2 - - -
GLENMARK PHARMACEUTICALS EUROPE13 - - -